Study Reveals How Cancer Immunotherapy Leads to Deadly Form of Heart Inflammation in Some Patients
The researchers found that damage to the heart is driven by a different immune response than the anti-tumor one, suggesting that this serious complication could one day be managed without halting cancer therapy.